Abstract P415: Etv2 Interacts With Vezf1 And Co-regulate Endothelial Gene Expression

染色质免疫沉淀 转录因子 生物 组蛋白 发起人 细胞生物学 锌指 关贸总协定6 分子生物学 锌指转录因子 免疫沉淀 遗传学 基因 基因表达
作者
Satyabrata Das,Vinayak Gupta,Wuming Gong,Javier Sierra-Pagan,Erik Skie,Mary G. Garry,Daniel J. Garry
出处
期刊:Circulation Research [Lippincott Williams & Wilkins]
卷期号:129 (Suppl_1)
标识
DOI:10.1161/res.129.suppl_1.p415
摘要

Background: Ets transcription factors function as important developmental regulators and are known to be modulators of cell fate. Previously, in conjunction with co-factors, we have described Ets variant 2 (Etv2) as an essential regulator of the hematopoietic and endothelial lineages. But the mechanism and the Etv2 interacting partners involved in achieving this critical function remains poorly understood. Results: Using a yeast two-hybrid assay, we identified Vascular Endothelial Zinc Finger 1 (Vezf1) as an interacting factor with Etv2. Vezf1 is a conserved C2H2 zinc finger transcription factor known to regulate the formation, proliferation, and migration of endothelial cells. We verified Vezf1 as a binding partner of Etv2 through co-immunoprecipitation and GST-pull down studies. Bioinformatics analysis of ChIP-seq and Etv2-expressing single cell RNA sequencing was conducted to identify candidate genes containing both Etv2 and Vezf1 binding motifs in their regulatory regions. Histone deacetylase 7 (Hdac7) and angiomotin like protein 2 (Amotl2) were identified as candidate genes and have previously been shown to function as regulators of endothelial development. RT-qPCR analysis showed upregulation of Hdac7 and Amotl2 in response to doxycycline inducible Etv2 and Vezf1; whereas significant reduction of expression of these two genes was observed in the Etv2 and Vezf1 knockout cells. Chromatin immunoprecipitation (ChIP) and electrophoresis mobility shift assays (EMSA) confirmed Etv2-Vezf1 adjacent binding sites in the promoters of Hdac7 and Amotl2. Histone Acetyl transferase (HAT) assays was performed to investigate Etv2-Vezf1 on global histone acetylation conditions in doxycycline inducible embryoid bodies. Vezf1 overexpression results in a significant reduction of acetylated histones. Additionally, we have undertaken ATAC-Seq (Assay for Transposase-Accessible Chromatin using sequencing) and Vezf1 ChIP-Seq studies to profile the epigenetic modifications and genome-wide occupancy of Vezf1 in the presence or absence of Etv2 in endothelial progenitor cells. Conclusion: In summary, this study identifies Vezf1 as a novel binding partner of Etv2 and we further demonstrate their combined role in the regulation of downstream target genes, Amotl2 and Hdac7, during endothelial development.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
iiq发布了新的文献求助10
1秒前
1秒前
2秒前
chuanxue发布了新的文献求助10
2秒前
3秒前
干饭选手又困了完成签到,获得积分10
3秒前
852应助减简采纳,获得10
4秒前
烟花应助减简采纳,获得10
4秒前
领导范儿应助减简采纳,获得10
4秒前
慕青应助减简采纳,获得10
4秒前
科研通AI6.3应助减简采纳,获得10
4秒前
CipherSage应助减简采纳,获得10
4秒前
5秒前
科研通AI6.2应助减简采纳,获得10
5秒前
C罗我男神发布了新的文献求助10
5秒前
李爱国应助减简采纳,获得10
5秒前
英姑应助减简采纳,获得10
5秒前
6秒前
6秒前
7秒前
7秒前
7秒前
JamesPei应助稳重的灵安采纳,获得10
10秒前
研友_Zr2mxZ完成签到,获得积分10
10秒前
科研通AI6.3应助减简采纳,获得10
11秒前
ding应助减简采纳,获得10
11秒前
所所应助减简采纳,获得10
11秒前
科研通AI6.2应助减简采纳,获得10
11秒前
小马甲应助减简采纳,获得10
12秒前
上官若男应助减简采纳,获得10
12秒前
科研通AI6.3应助减简采纳,获得10
12秒前
田様应助减简采纳,获得10
12秒前
科研通AI6.3应助减简采纳,获得10
12秒前
大个应助减简采纳,获得10
12秒前
Akim应助zl采纳,获得10
13秒前
13秒前
xiaoyi完成签到,获得积分10
16秒前
ShanYexia完成签到,获得积分10
16秒前
每天都是新的一天完成签到,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Resiliency Scale for Adolescents--Chinese Version 600
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7320105
求助须知:如何正确求助?哪些是违规求助? 8935806
关于积分的说明 18943225
捐赠科研通 6978514
什么是DOI,文献DOI怎么找? 3214432
关于科研通互助平台的介绍 2382327
邀请新用户注册赠送积分活动 2193521